Affiliation:
1. Department of Chemistry and Biochemistry, University of Southern Mississippi, Hattiesburg, MS 39406, USA
Abstract
Allosteric HIV-1 Integrase (IN) Inhibitors or ALLINIs bind at the dimer interface of the IN, away from the enzymatic catalytic site, and disable viral replication by inducing over-multimerization of IN. Interestingly, these inhibitors are capable of impacting both the early and late stages of viral replication. To better understand the important binding features of multi-substituted quinoline-based ALLINIs, we have surveyed published studies on IN multimerization and antiviral properties of various substituted quinolines at the 4, 6, 7, and 8 positions. Here we show how the efficacy of these inhibitors can be modulated by the nature of the substitutions at those positions. These features not only improve the overall antiviral potencies of these compounds but also significantly shift the selectivity toward the viral maturation stage. Thus, to fully maximize the potency of ALLINIs, the interactions between the inhibitor and multiple IN subunits need to be simultaneously optimized.
Funder
National Institutes of Health
Subject
Virology,Infectious Diseases
Reference48 articles.
1. Smith, S.J., Zhao, X.Z., Passos, D.O., Lyumkis, D., Burke, T.R., and Hughes, S.H. (2021). Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs. Viruses, 13.
2. Evolution of HIV integrase resistance mutations;Quashie;Curr. Opin. Infect Dis.,2013
3. Richetta, C., Tu, N.Q., and Delelis, O. (2022). Different Pathways Conferring Integrase Strand-Transfer Inhibitors Resistance. Viruses, 14.
4. Structure and function of HIV-1 integrase;Chiu;Curr. Top Med. Chem.,2004
5. Retroviral Integrase Structure and DNA Recombination Mechanism;Engelman;Microbiol. Spectr.,2014